Cinctive Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Buy |
+3,109
| New | +$1.63M | 0.09% | 228 |
|
|
2024
Q4 | – | Sell |
-2,973
| Closed | -$3.13M | – | 443 |
|
|
2024
Q3 | $3.13M | Sell |
2,973
-6,711
| -69% | -$7.05M | 0.17% | 176 |
|
|
2024
Q2 | $10.2M | Buy |
9,684
+797
| +9% | +$838K | 0.48% | 47 |
|
|
2024
Q1 | $8.55M | Buy |
8,887
+2,887
| +48% | +$2.78M | 0.4% | 61 |
|
|
2023
Q4 | $5.27M | Buy |
+6,000
| New | +$5.27M | 0.35% | 96 |
|